Search Results - "Amelse, L. L."

Retrospective analysis of local injection site adverse reactions associated with 230 allogenic administrations of bone marrow‐derived mesenchymal stem cells in 164 horses by Ursini, T. L., Amelse, L. L., Elkhenany, H. A., Odoi, A., Carter‐Arnold, J. L., Adair, H. S., Dhar, M. S.

“…Summary Background Bone marrow‐derived mesenchymal stem cells (BM‐MSCs) are frequently used in the treatment of musculoskeletal injuries. Fully characterised…”
Get full text

In vitro analysis of equine, bone marrow‐derived mesenchymal stem cells demonstrates differences within age‐ and gender‐matched horses by Carter‐Arnold, J. L, Neilsen, N. L, Amelse, L. L, Odoi, A, Dhar, M. S

“…REASONS FOR PERFORMING THE STUDY: Stem cell therapies are used routinely in equine practice. Most published reports characterise stem cells derived from…”
Get full text

Genetic profiling of human bone marrow and adipose tissue-derived mesenchymal stem cells reveals differences in osteogenic signaling mediated by graphene by MacDonald, Amber F, Trotter, Ruby D, Griffin, Christopher D, Bow, Austin J, Newby, Steven D, King, William J, Amelse, Lisa L, Masi, Thomas J, Bourdo, Shawn E, Dhar, Madhu S

“…In the last decade, graphene surfaces have consistently supported osteoblast development of stem cells, holding promise as a therapeutic implant for…”
Get full text

Kisspeptin receptor agonist (FTM080) increased plasma concentrations of luteinizing hormone in anestrous ewes by Whitlock, Brian K, Daniel, Joseph A, Amelse, Lisa L, Tanco, Valeria M, Chameroy, Kelly A, Schrick, F Neal

“…Kisspeptin receptor (KISS1R) agonists with increased half-life and similar efficacy to kisspeptin in vitro may provide beneficial applications in breeding…”
Get full text

Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets by CHAVEZ-REYES, Arturo, PARANT, John M, AMELSE, Lisa L, MONTES DE OCA LUNA, Roberto, KORSMEYER, Stanley J, LOZANO, Guillermina

“…The p53 tumor suppressor ensures maintenance of genome integrity by initiating either apoptosis or cell cycle arrest in response to DNA damage. Deletion of…”
Get full text

Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null mice by McDonnell, Timothy J., Montes de Oca Luna, Roberto, Cho, Song, Amelse, Lisa L., Chavez-Reyes, Arturo, Lozano, Guillermina

“…The transcriptional activity of the p53 tumour suppressor is inhibited by binding to MDM2. The in vivo significance of this interaction was established in mdm2…”
Get full text

Effects of stacked wedge pads and chains applied to the forefeet of Tennessee Walking Horses for a five-day period on behavioral and biochemical indicators of pain, stress, and inflammation by Everett, James B, Schumacher, Jim, Doherty, Thomas J, Black, Randi A, Amelse, Lisa L, Krawczel, Peter, Coetzee, Johann F, Whitlock, Brian K

“…OBJECTIVE To determine the effects of stacked wedge pads and chains applied to the forefeet of Tennessee Walking Horses on behavioral and biochemical…”
Get full text

Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality by de Oca Luna, Roberto Montes, Amelse, Lisa L, Chavez-Reyes, Arturo, Evans, Susan C, Brugarolas, James, Jacks, Tyler, Lozano, Guillermina

“…The MDM2 protein negatively regulates the activity of the p53 tumour suppressor by binding its transcriptional activation domain. In fact, the early embryonic…”
Get full text

Overproduction of MDM2 in vivo disrupts S phase independent of E2F1 by REINKE, V, BORTNER, D. M, AMELSE, L. L, LUNDGREN, K, ROSENBERG, M. P, FINLAY, C. A, LOZANO, G

“…Expression of a beta-lactoglobulin (BLG)/mdm2 transgene (BLGmdm2) in the epithelial cells of the mouse mammary gland causes an uncoupling of S phase from M…”
Get full text

Loss of one but not twomdm2 null alleles alters the tumour spectrum inp53 null mice by McDonnell, Timothy J., Montes de Oca Luna, Roberto, Cho, Song, Amelse, Lisa L., Chavez-Reyes, Arturo, Lozano, Guillermina

Get full text